Corvus Pharmaceuticals, Inc.【CRVS】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -381,800 +12.2%
4Q24 -397,000 +18.6%
3Q24 -384,897 +17.3%
2Q24 -344,700 +7.0%
1Q24 -340,400 +7.9%
4Q23 -334,700 +8.8%
3Q23 -328,100 +10.1%
2Q23 -322,100 +13.8%
1Q23 -315,600 +14.9%
4Q22 -307,700 +15.5%
3Q22 -297,900 +15.9%
2Q22 -283,000 +14.8%
1Q22 -274,700 +17.0%
4Q21 -266,381 +19.4%
3Q21 -257,100 +2.6%
2Q21 -246,500 +2.4%
1Q21 -234,700 +2.0%
4Q20 -223,100 +2.8%
3Q20 -250,500 +21.5%
2Q20 -240,700 +23.4%
1Q20 -230,080 +26.3%
4Q19 -217,100 +27.4%
3Q19 -206,098 +28.8%
2Q19 -195,094 +30.5%
1Q19 -182,116 +32.1%
4Q18 -170,473 +38.0%
3Q18 -159,963 +43.3%
2Q18 -149,466 +51.1%
1Q18 -137,835 +64.3%
4Q17 -123,534 +82.0%
3Q17 -111,605 +96.5%
2Q17 -98,888 +112.7%
1Q17 -83,907 +121.7%
4Q16 -67,871 -
3Q16 -56,785 -
2Q16 -46,488 -
1Q16 -37,843 -